FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Bumetanide Injection, USP
Status: Currently in Shortage
»Date first posted: 12/13/2017
»Therapeutic Categories: Cardiovascular

Expand all

Hospira, Inc. (Reverified 04/09/2019)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/4 mL (0.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1412-04) Next Delivery and Estimated Recovery: December 2019 Shortage per Manufacturer: Manufacturing Delay Other
2.5 mg/10 mL (0.25 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1412-10) Next Delivery and Estimated Recovery: March 2020 Shortage per Manufacturer: Manufacturing Delay Other

West-Ward Pharmaceuticals (Revised 12/18/2018)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.25 mg/mL, 4 mL vial (NDC 0641-6008-10) Inventory is currently available. Additional lots are scheduled to be manufactured in the December 2018 timeframe. Product will be made available as it is released. Demand increase for the drug
0.25 mg/mL, 10 mL vial (NDC 0641-6007-10) Inventory is currently available. Additional lots are scheduled to be manufactured in the January 2019 timeframe. Product will be made available as it is released. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English